Emerging Diagnostic Technologies in the Changing U.S. Market
Report Highlights
The U.S. emerging diagnostic technologies market was valued at $880 million in 2011 and should reach $1.2 billion in 2012. Total market value is expected to reach $3.2 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 20.9%.
Report Scope
This report addresses the U.S. market for emerging diagnostic technologies. Of course, terms such as emerging or new are relative in a rapidly evolving market such as medical diagnostics. Thus, this report pragmatically defines emerging diagnostic technologies as those that are only in limited commercial use and/or in advanced development as of 2012. Also included are certain technologies, such as telemedicine, that have been in use for more than a few years, but which have the potential today to cause a fundamental or paradigm shift in the way diagnoses are performed. The technologies covered fall into the following categories:
- Ultrasound.
- Magnetic resonance imaging.
- Nuclear medicine.
- Computed tomography.
- Photonics, optics and spectroscopy.
- Hybrid imaging technologies.
- Telediagnosis.
- Laboratory information systems.
- Diagnostic decision support systems.
- Imaging agents.
- Terahertz technology.
- Wireless devices.
- Other technologies.
The format of the study includes the following elements:
- Summary.
- Definitions.
- Developments in enabling technologies.
- Key end-user segments.
- Market environment (legal and regulatory, standards, trends in the healthcare industry, demographic and economic trends, other market drivers and barriers to deployment).
- Emerging diagnostic technologies and products.
- Detailed market estimates and projections, by type of diagnostic technology and product, 2011 to 2017.
- Supplier profiles.
- Patent analysis.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
- Implosion Manufacturing: Novel Nanotech Methods for Next Generation Materials (NAN065A)
- Civil engineering Services for Public Works Infrastructure Projects: North America (ENG023A)
- Organic Foods and Beverages: Global Markets (FOD067B)
- Bionics: Technologies and Global Markets (HLC196B)
- The Market for Minimally Invasive Medical Devices (HLC051H)